The news: Health insurer Elevance Health is requesting over $1 million in repayments from healthcare providers for allegedly inappropriately prescribing Ozempic to their patients, according to a Bloomberg report.

Digging into the details: Elevance’s Anthem Blue Cross Blue Shield health plan contacted a small number of providers for their alleged excessive off-label prescribing of Ozempic.

For context, Ozempic is FDA-approved to treat type 2 diabetes but is commonly prescribed off-label for weight loss. Elevance said that Anthem only covers Ozempic for diabetes.

You've read 0 of 2 free articles this month.

Get more articles - create your free account today!

Products

Events & Resources

Topics

Latest Articles

Shoppers hate paying for return shipping more than any other part of the process

Doctors expect longer visits as parents seek clarity about pediatric vaccine guidelines

Lowe’s reaches out to Gen Alpha with new rewards program for kids

Meta faces critical questions as AI spending and regulatory scrutiny intensify

J&J launches direct-to-consumer prescription drug site with lower cash prices

The health and fitness industry’s future is subscription-first, not hardware-led

Scam exposure on social platforms threatens brands

Email is consumers’ top marketing channel, but inbox fatigue threatens ROI

How payment providers should react to OpenAI’s Instant Checkout walkback

Capital One joins finance industry layoff trend, sheds 1,100 Discover workers

About

Elevance requests repayment from doctors for overprescribing Ozempic

Coverage Areas →

Coverage Areas →

Advertising & Marketing

Health

Ecommerce & Retail

Technology

Financial Services

More Topics

Geographies

EMARKETER

Media Services

Free Content

Contact Us →

Worldwide HQ

Sales Inquiries